Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In June: Earnings Summary

TRACON Pharmaceuticals

15/08/2023 24:39

* TRACON Pharmaceuticals Inc  TCON.OQ  reported quarterly
adjusted
earnings of 22 cents​​ per share for the quarter ended in June.
The mean expectation of four analysts for the quarter was for a
loss of 10 cents per share.
    * Revenue was $9.00 million​; analysts expected $2.25
million. 
    * TRACON Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 20 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * TRACON Pharmaceuticals Inc shares had risen by 10.0% this
quarter and lost 78.5% so far this year.
    * The company reported a quarterly loss of $6.29 million.
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 11:39 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.10          0.22           Beat
 Mar. 31 2023      -0.26          -0.36          Missed
 Dec. 31 2022      -0.27          -0.31          Missed
 Sep. 30 2022      -0.28          -0.30          Missed